FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YANG, H.
Right arrow Articles by LU, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YANG, H.
Right arrow Articles by LU, S. C.
(The FASEB Journal. 2001;15:1507-1516.)
© 2001 FASEB

The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma

HEPING YANG, ZONG-ZHI HUANG, JIAOHONG WANG and SHELLY C. LU1

Division of Gastroenterology and Liver Diseases, USC Liver Disease Research Center, USC-UCLA Research Center for Alcoholic Liver and Pancreatic Diseases, Keck School of Medicine USC, Los Angeles, California 90033, USA

1Correspondence: Division of Gastrointestinal and Liver Diseases, HMR Bldg. 415, Department of Medicine, USC School of Medicine, 2011 Zonal Ave., Los Angeles, CA 90033, USA. E-mail: shellylu{at}hsc.usc.edu

Liver-specific and non-liver-specific methionine adenosyltransferase (MAT) are products of two genes, MAT1A and MAT2A, respectively, that catalyze the formation of S-adenosylmethionine. We showed a switch from MAT1A to MAT2A expression at the transcriptional level in human hepatocellular carcinoma (HCC) that facilitates cancer cell growth. The purpose of the present study was to better understand the molecular mechanism of increased MAT2A expression in HCC. In vitro DNase I footprinting analysis revealed two protected sites (-354 to -312 and -73 to -28) using nuclear proteins from HCC and HepG2 cells, but not normal liver. These sites are also protected in HepG2 cells on in vivo DNase I footprinting analysis. These protected sites contain consensus binding sites for c-Myb and Sp1. In HCC, the mRNA levels of c-myb and Sp1 and binding to their respective sites increased. Mutation of the c-Myb or Sp1 site reduced MAT2A promoter activity by 67% and 50%, respectively. The importance of these cis-acting elements and trans-activating factors was confirmed using heterologous promoter and expression vectors. Increased expression of c-Myb and Sp1 and binding to the MAT2A promoter contribute to transcriptional up-regulation of MAT2A in HCC.—Yang, H., Huang, Z.-Z., Wang, J., Lu, S. C. The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma.


Key Words: methionine adenosyltransferase • transcriptional regulation • HCC • S-adenosylmethionine




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Yang, M. R. Sadda, V. Yu, Y. Zeng, T. D. Lee, X. Ou, L. Chen, and S. C. Lu
Induction of Human Methionine Adenosyltransferase 2A Expression by Tumor Necrosis Factor {alpha}: ROLE OF NF-{kappa}B AND AP-1
J. Biol. Chem., December 19, 2003; 278(51): 50887 - 50896.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. M. MATO, F. J. CORRALES, S. C. LU, and M. A. AVILA
S-Adenosylmethionine: a control switch that regulates liver function
FASEB J, January 1, 2002; 16(1): 15 - 26.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The Federation of American Societies for Experimental Biology.